Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Actinium Pharmaceuticals (ATNM) Gains from Investment Securities (2021 - 2025)

Actinium Pharmaceuticals (ATNM) has disclosed Gains from Investment Securities for 5 consecutive years, with $3000.0 as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities changed N/A to $3000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $6000.0 through Dec 2025, changed N/A year-over-year, with the annual reading at $61000.0 for FY2025, 577.78% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $3000.0 at Actinium Pharmaceuticals, down from $36000.0 in the prior quarter.
  • The five-year high for Gains from Investment Securities was $4.9 million in Q1 2025, with the low at $1.0 in Q3 2021.
  • Average Gains from Investment Securities over 5 years is $359784.0, with a median of $3192.0 recorded in 2022.
  • The sharpest move saw Gains from Investment Securities crashed 100.0% in 2022, then soared 34999900.0% in 2025.
  • Over 5 years, Gains from Investment Securities stood at $22000.0 in 2021, then plummeted by 95.45% to $1000.0 in 2022, then changed by 0.0% to $1000.0 in 2023, then surged by 421.6% to $5216.0 in 2024, then tumbled by 42.48% to $3000.0 in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $3000.0, $36000.0, and $4923.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.